Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-09

Clinical Trial Update: Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating efficacy and safety of valsartan alone and in combination with simvastatin for hypertension and hypercholesterolemia/dyslipidemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)
  • VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: Hypertension, Hypercholesterolemia | Phase 3 | Status: COMPLETED